Walmsley Looks Safe For Now, But GSK Faces M&A Pressure

Strategy Debate Will Rumble On

 
• By Andrew McConaghie
  
GSK
Major investors have backed Emma Walmsley as CEO - but will want to see their patience rewarded
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip